Sidoroff A
Univ.-Klinik für Dermatologie und Venerologie, Medizinische Universität Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Hautarzt. 2007 Jul;58(7):577-84. doi: 10.1007/s00105-007-1348-3.
During the last years photodynamic therapy (PDT) has progressively established itself as a standard treatment for non-melanoma skin cancer. A number of clinical studies have demonstrated its efficacy--also compared to other treatment modalities--as well as good acceptance by patients and outstanding cosmetic results. For Bowen disease and superficial basal cell carcinoma, PDT can be regarded as the first-line non-invasive treatment. In the treatment of actinic keratoses PDT should be considered when cosmesis is crucial or in cases of field cancerization. In nodular basal cell carcinoma, effectiveness for lesions up to a thickness of 2 mm is well documented. In summary the evidence level seems sufficient to regard PDT as valuable treatment modality of which patients should not be deprived.
在过去几年中,光动力疗法(PDT)已逐渐成为非黑色素瘤皮肤癌的标准治疗方法。多项临床研究已证明其疗效——与其他治疗方式相比——以及患者的良好接受度和出色的美容效果。对于鲍温病和浅表性基底细胞癌,PDT可被视为一线非侵入性治疗方法。在治疗光化性角化病时,当美容至关重要或存在场癌化情况时,应考虑使用PDT。在结节性基底细胞癌中,对于厚度达2毫米的病变,其有效性已有充分记录。总之,证据水平似乎足以将PDT视为一种有价值的治疗方式,不应剥夺患者使用该方法的权利。